The Challenges and Opportunities of Testosterone Therapy for Menopausal Women

Current Landscape of Testosterone Therapy

Women who inquire about testosterone for menopause symptoms often face insurance hurdles and dosing uncertainties. Currently, no testosterone product is approved by the FDA for women in the U.S.

Recently, the FDA held a public workshop to discuss the evidence, safety, and research gaps related to testosterone therapy for menopausal women. Interest in this therapy is increasing as women seek help for issues like low sexual desire and fatigue during menopause.

Lack of FDA-Approved Options

Due to the absence of an FDA-approved product, doctors prescribe testosterone off-label. They turn to compounded formulations or use micro-doses of male products. Dr. Kudzai Dombo, an obstetrician-gynecologist, describes this situation as a common challenge in her Los Angeles practice.

While social media and peer discussions often highlight various potential benefits of testosterone, the guidelines support it solely for hypoactive sexual desire disorder (HSDD). Evidence for other benefits remains minimal.

Challenges in Administration and Access

The current situation forces patients to rely on compounded creams or foreign purchases. Doctors often use custom compounding pharmacies or split male gel packets. However, these methods complicate the dosing process, as seen in cases where patients’ hormone levels remain unchanged even with precise measurements.

Insurance companies refuse to cover off-label prescriptions, so patients face financial and administrative obstacles. Dombo shared her own experience of trying different testosterone products due to coverage issues.

Push for Standardization

Advocacy from both patients and healthcare providers has pushed for official evaluation by regulators. Dombo emphasizes the importance of sexual health as part of overall well-being and remains hopeful about improved access.

The recent federal meeting marks progress, and continuous advocacy is essential in achieving standardized access to testosterone therapy for women.

Khloe Quill, a lifestyle writer with Fox News Digital, contributes to stories on health, travel, food, and more.